17-Hydroxyprogesterone (Pre-menopausal)

Decreased levels of 17-Hydroxyprogesterone (17-OHP) in pre-menopausal women can indicate several potential conditions or imbalances. Since 17-OHP is involved in the synthesis of other important hormones like cortisol and progesterone, lower-than-normal levels may suggest:

1. Adrenal Insufficiency: Low levels of 17-OHP could point to a dysfunction in the adrenal glands, where 17-OHP is produced. This may indicate conditions like Addison's disease, where the adrenal glands do not produce enough hormones.

2. Hypopituitarism: This condition involves decreased secretion of hormones by the pituitary gland, which can affect the production of various hormones, including 17-OHP.

3. Low Ovarian Reserve: Decreased levels may reflect reduced ovarian function or a lower number of functioning follicles, which can be a concern for fertility.

4. Hypothyroidism: Low thyroid function can sometimes impact adrenal and ovarian hormone production, leading to decreased levels of 17-OHP.

It's important to interpret decreased 17-OHP levels in the context of other hormonal markers and clinical symptoms. A healthcare provider may recommend further testing or treatment depending on the underlying cause of the low levels.

17-Hydroxyprogesterone (17-OHP) is a steroid hormone produced by the adrenal glands and ovaries. On a Sex Hormones Profile; Urine (female) panel by Doctor's Data, the 17-Hydroxyprogesterone (Pre-menopausal) marker measures the levels of this hormone in urine.

In pre-menopausal women, 17-OHP plays a crucial role in the production of other hormones, including cortisol and estrogen. It is involved in the progesterone synthesis pathway and can help in assessing adrenal and ovarian function. Elevated or abnormal levels of 17-OHP may indicate a variety of conditions, including polycystic ovary syndrome (PCOS), congenital adrenal hyperplasia (CAH), or adrenal gland disorders.